Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
The New Era Fund is a venture capital organization founded to support entrepreneurs developing technologies and consumer products that enhance human health, performance, and potential. Established in the United States, the fund emphasizes investments in companies that gain initial validation from elite sports environments while targeting broader markets such as military, healthcare, and consumer sectors.
Currently, the fund operates with a team of three partners and focuses on seed and Series A investments. The New Era Fund aims to empower founders by providing not only capital but also strategic guidance, industry connections, and operational support. The firm is positioned to facilitate introductions and partnerships that can accelerate growth and market entry for its portfolio companies.
As of now, the fund has invested in five notable companies, showcasing its commitment to advancing human health and performance through innovative solutions. The New Era Fund is recognized for its unique approach to leveraging elite sports as a validation point for its investments.
The New Era Fund primarily invests in seed and Series A stage companies, with check sizes ranging from $9,000 to $32,000. The fund's investment strategy centers around three key areas: health, performance, and potential. In the health sector, the fund looks for products and services that protect, restore, and optimize the human body. For performance, the focus is on enhancing physical output and competitive advantage. In terms of potential, the fund seeks products that expand cognitive performance and personal development.
The New Era Fund emphasizes the importance of validation from elite sports environments, which serves as a critical proof point for the companies it backs. This validation allows portfolio companies to expand into larger markets, including military, healthcare, industrial, and consumer sectors. The fund is particularly interested in companies that have a clear path to validation by professional teams, athletes, trainers, or performance staff, ensuring that their solutions are not only innovative but also practical and scalable.
The New Era Fund's portfolio includes five notable companies:
These companies exemplify the fund's focus on health and performance innovations, each leveraging unique technologies to address specific needs in their respective markets. The New Era Fund's commitment to supporting these ventures highlights its strategy of investing in solutions that have the potential to scale beyond initial validation in elite sports.
Sean Clifford: General Partner at The New Era Fund, Sean has a background in professional sports and venture capital. He brings extensive experience in identifying and supporting innovative health and performance technologies.
Liam Clifford: General Partner, Liam co-hosts the Playbooks & Portfolios podcast and is involved in sourcing and evaluating investment opportunities within the fund's focus areas.
Daniel Bodisch: Managing Partner, Daniel has a strong track record in venture capital and operational support, focusing on helping portfolio companies scale effectively in their respective markets.
To pitch The New Era Fund, founders should visit the contact page on their website. It is advisable to include a comprehensive overview of the startup, detailing the product, market opportunity, and any validation received from elite sports environments. The fund prefers pitches that clearly outline the potential for downstream expansion into larger markets.
Response times may vary, but founders should expect to hear back within a few weeks. Warm introductions are encouraged, as they can significantly enhance the chances of securing a meeting with the fund's partners.
As of April 2026, The New Era Fund continues to actively seek investment opportunities in seed and Series A stage companies. The fund has recently highlighted its commitment to supporting innovations in health and performance, particularly those validated by elite sports.
In 2025, the fund announced its participation in several funding rounds for its portfolio companies, including significant investments in health technology and performance-enhancing products. The New Era Fund's strategic approach to leveraging elite sports as a validation point remains a cornerstone of its investment thesis.
What are the investment criteria for The New Era Fund?
The New Era Fund primarily invests in seed and Series A stage companies that focus on health, performance, and potential. They look for products that have already gained validation from elite sports environments and have a clear path for expansion into larger markets.
How can I apply or pitch to The New Era Fund?
What makes The New Era Fund different from other investors?
The New Era Fund differentiates itself by focusing on technologies and consumer products that enhance human health and performance, specifically those validated by elite sports. Their team provides not just capital but also strategic guidance and industry connections to accelerate growth.
What is the geographic scope of The New Era Fund?
The New Era Fund primarily invests in companies based in the United States, although their portfolio companies may target broader markets.
What is the typical check size for investments?
The New Era Fund typically invests between $9,000 and $32,000 in seed and Series A stage companies, depending on the specific needs and potential of the startup.
What kind of post-investment involvement can founders expect?
The New Era Fund provides operational support, strategic guidance, and access to industry connections to help portfolio companies scale effectively. Their team leverages their expertise in professional sports to facilitate introductions and partnerships that can enhance growth.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.